✦ LIBER ✦

Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

✍ Scribed by Ivette F Emery; Chiara Battelli; Paul L Auclair; Kathleen Carrier; Daniel M Hayes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib response of EGFR-mutant gefiti

✍ Chang, John Wen-Cheng; Chou, Chun-Liang; Huang, Shiu-Feng; Wang, Hung-Ming; Hsie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 414 KB

Erlotinib in advanced non-small-cell lun

✍ Zheng-Tao Zhou; Xin-Hua Xu; Qing Wei; Ming-qian Lu; Jie Wang; Cai-Hong Wen 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 262 KB

Alveolar hemorrhage due to erlotinib in

✍ Yano Shuichi 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 262 KB

Erlotinib, docetaxel, and gefitinib in s

✍ Popat, Sanjay; Barbachano, Yolanda; Ashley, Sue; Norton, Alison; O’Brien, Mary 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Lack of response to erlotinib after prog

✍ Viswanathan, Avinash; Pillot, Giancarlo; Govindan, Ramaswamy 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Comparison of adverse events and efficac

✍ Tsukasa Yoshida, Kazuhiko Yamada, Koichi Azuma, Akihiko Kawahara, Hideyuki Abe, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 225 KB